To hear about similar clinical trials, please enter your email below

Trial Title: Comparison of Three Different Puncture Techniques in EBUS-TBNA

NCT ID: NCT05628454

Condition: Lung Cancer
Sarcoidosis
Tuberculosis

Conditions: Official terms:
Tuberculosis
Sarcoidosis

Study type: Interventional

Study phase: N/A

Overall status: Recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Diagnostic

Masking: Double (Participant, Outcomes Assessor)

Masking description: The operator knows which puncture technique to be used, but the subject and the outcomes assessor does not know the technique.

Intervention:

Intervention type: Procedure
Intervention name: Endobronchial ultrasound-guided transbronchial needle Slow-pull capillary sampling
Description: The slow-pull capillary technique was performed as follows: after identification and measurement of the target lymph node, a needle was used to puncture the lymph node with the stylet in place.At the same time, the stylet was slowly and continuously pulled to create weak negative pressure.
Arm group label: EBUS-TBNSP

Other name: Slow-pull capillary technique

Intervention type: Procedure
Intervention name: Endobronchial ultrasound-guided transbronchial needle aspiration
Description: The operation steps are the same as above, but the negative pressure device of 10ml syringe is connected behind the puncture needle.
Arm group label: EBUS-TBNA

Other name: Standard suction

Intervention type: Procedure
Intervention name: Endobronchial ultrasound-guided transbronchial needle capillary sampling
Description: The operation steps are the same as above, but there is no negative pressure device behind the puncture needle
Arm group label: EBUS-TBNCS

Other name: Fine needle sampling without suction

Summary: The purpose of this study was to compare the accuracy and sensitivity of slow-pull capillary technique, traditional suction aspiration and non negative pressure puncture in the diagnosis of mediastinal and/or hilar lymph node enlargement by ultrasound bronchoscopic lymph node biopsy.

Detailed description: EBUS-TBNA has been widely used in the diagnosis of diseases involving lung hilar and mediastinal lymph node enlargement.But different puncture methods are still controversial. Research shows that there was no significant difference in sample adequacy, diagnostic specificity and accuracy between the no negative pressure aspiration and traditional negative pressure aspiration technique.Slow-pull capillary technique is a relatively new operating method of endoscopic ultrasound guided fine needle biopsy in recent years. At present, this technology is widely used in pancreatic space occupying lesions. Compared with the traditional negative pressure aspiration method, our previous retrospective study found that the slow-pull capillary technique can improve the diagnostic accuracy of patients. Therefore, the purpose of this study is to prospectively and randomly compare the advantages and disadvantages of three puncture methods in EBUS-TBNA.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Age 18-80years - Chest computed tomography showing hilar or mediastinal lymph node enlargement - No contraindications for bronchoscopy - Signed informed consent provided by the patient - Disease needs to be diagnosed through the EBUS-TBNA Exclusion Criteria: - Severe coagulation dysfunction - Severe cardiopulmonary dysfunction - Acute asthma attack or massive haemoptysis - Poor general condition - Physical weakness without tolerance for anaesthesia or allergy to narcotic drug - Disease can be diagnosed by other less invasive methods (such as skin or peripheral superficial lymph node biopsy)

Gender: All

Minimum age: 18 Years

Maximum age: 80 Years

Healthy volunteers: No

Locations:

Facility:
Name: Beijing Friendship Hospital, Capital Medical University

Address:
City: Beijing
Zip: 100050
Country: China

Status: Recruiting

Contact:
Last name: Ganggang Yu

Phone: 0086-13717970816
Email: gangyu.603@163.com

Start date: November 1, 2022

Completion date: November 1, 2024

Lead sponsor:
Agency: Beijing Friendship Hospital
Agency class: Other

Source: Beijing Friendship Hospital

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05628454

Login to your account

Did you forget your password?